Panavance Therapeutics

Pharmaceutical Manufacturing · 2 Employees
Phone Number: 16109221910
  • Overview
  • Employees
Access 8 Verified Employees Profiles for Panavance TherapeuticsUnlock Free Contacts Now
About
Panavance Therapeutics Inc. is a US, clinical-stage pharmaceutical company established in 2021 by the Swiss-based Avensis Pharma AG, a subsidiary of Ed. Geistlich Söhne AG für Chemische Industrie. Panavance is focused on advancing the development of GP-2250, a novel oncology therapeutic intended to improve outcomes and quality of life for patients with cancer. With its highly capable team and strong academic and industry partnerships, Panavance is pursuing a rigorous program to bring GP-2250 to patients around the world.
Year Founded
2021
Social Media
LinkedinTwitter
Industry
Pharmaceutical Manufacturing
HQ Location
1055 Westlakes Dr Suite 300 Berwyn, Pennsylvania 19312, US
Keywords
--
Location
  • 1055 Westlakes Dr Suite 300 Berwyn, Pennsylvania 19312, US

Email Formats

Sign up for free credits and discover verified email addresses of Panavance Therapeutics
FormatExamples
first + last
andywarhol@panavance.com
first_initial + last
awarhol@panavance.com
first + last_initial
andyw@panavance.com
first
andy@panavance.com
last
warhol@panavance.com
Get Verified Emails for 8 Panavance Therapeutics Employees

Frequently Asked Questions

Learn More about Panavance Therapeutics

Similar Companies

Pharmaceutical Manufacturing

Get key business info for Panavance Therapeutics and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.